Categories Earnings, Energy

Earnings Summary: A snapshot of Ameren’s Q4 2023 financial results

Ameren Corp (NYSE: AEE), a leading public utility holding company, has announced financial results for the fourth quarter of 2023. The company also issued guidance for 2024 earnings and long-term growth.

  • Q4 net income declined to $158 million or $0.60 per share from $163 billion or $0.63 per share a year earlier
  • Total operating revenues decreased to $1.62 billion in the fourth quarter from $2.05 billion a year earlier
  • At $264 million, Q4 operating income was down 4% year-over-year
  • The management expects full-year 2024 earnings per share to be in the range of $4.52 to $4.72
  • At the midpoint of the FY4 guidance, the company expects earnings to grow at a 6% to 8% compound annual rate from 2024 through 2028
  • The multi-year earnings growth is expected to be driven by projected rate base growth of about 8.2% compounded annually from 2023 through 2028

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q2 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported its second quarter 2024 earnings results today. Net sales increased 4.9% year-over-year to $5 billion. Organic sales increased 9%. Net income attributable to Colgate-Palmolive Company was $731

Key takeaways from Visa’s Q3 2024 earnings report

Credit card behemoth Visa, Inc. (NYSE: V) this week reported mixed results for the June quarter, with earnings matching expectations and sales slightly missing the view. Both numbers grew in

Southwest Airlines (LUV): A look at the airline’s performance in Q2 2024

Shares of Southwest Airlines Co. (NYSE: LUV) were up over 6% on Thursday after the company beat earnings estimates for the second quarter of 2024. The stock has gained 4%

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top